Improved tumour response prediction with equivalent uniform dose in pre-clinical study using direct intratumoural infusion of liposome-encapsulated 186Re radionuclides

Physics in Medicine and Biology

Volumn 56, Issue 17, 2011, Pages 5721-5734

  Hrycushko, Brian A ^a   Ware, Steve ^a   Li, Shihong ^a   Bao, Ande ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABSORBED DOSE; ADDITIONAL TREATMENT; CANCER THERAPY; DOSE RESPONSE; DOSE RESPONSE RELATIONSHIPS; EQUIVALENT UNIFORM DOSE; HEAD-AND-NECK SQUAMOUS CELL CARCINOMA; IMPROVED PREDICTABILITY; KERNEL CONVOLUTION; PRE-CLINICAL; RADIOACTIVITY DISTRIBUTION; RADIOBIOLOGICAL PARAMETERS; RESPONSE PREDICTION; STRONG CORRELATION; TREATMENT PLANNING; TUMOUR PROGRESSION;

CONVOLUTION; DISEASES; ONCOLOGY;

TUMORS;

LIPOSOME; RADIOISOTOPE; RHENIUM;

ALGORITHM; ANIMAL; ARTICLE; COMPUTER ASSISTED RADIOTHERAPY; DISEASE MODEL; HEAD AND NECK TUMOR; HUMAN; INTRALESIONAL DRUG ADMINISTRATION; METABOLISM; METHODOLOGY; NUDE RAT; RADIATION DOSE; RADIATION RESPONSE; RAT; TREATMENT OUTCOME; TUMOR CELL LINE; XENOGRAFT;

ALGORITHMS; ANIMALS; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, RADIATION; HEAD AND NECK NEOPLASMS; HUMANS; INFUSIONS, INTRALESIONAL; LIPOSOMES; RADIOISOTOPES; RADIOTHERAPY DOSAGE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RATS; RATS, NUDE; RHENIUM; TRANSPLANTATION, HETEROLOGOUS; TREATMENT OUTCOME;

EID: 80052074328     PISSN: 00319155     EISSN: 13616560     Source Type: Journal    
DOI: 10.1088/0031-9155/56/17/016     Document Type: Article

References (32)

1. 131I-tositumomab therapy J. Nucl. Med. 51 654-9
2. Bao A, Zhao X, Phillips W T, Woolley F R, Otto R A, Goins B and Hevezi J M 2005 Theoretical study of the influence of a heterogeneous activity distribution on intratumoural absorbed dose distribution Med. Phys. 32 200-8 (Pubitemid 40165532)
3. Bao A, Phillips W T, Goins B, McGugg H S, Zheng X, Woolley F R, Natarajan M, Santoyo C, Miller F R and Otto R A 2006 Setup and characterization of a human head and neck squamous cell carcinoma xenograft model in nude rats Otolaryngol. Head Neck Surg. 135 853-7 (Pubitemid 44820627)
4. Bischof Delaloye A 2000 Radioimmunoimaging and radioimmunotherapy: will these be routine procedures? Semin. Nucl. Med. 30 186-94
5. Butler W M, Stewart R R and Merrick G S 2009 A detailed radiobiologic and dosimetric analysis of biochemical outcomes in a case-control study of permanent prostate brachytherapy patients Med. Phys. 36 776-87
6. Dale R G and Jones B 1998 The clinical radiobiology of brachytherapy Br. J. Radiol. 71 465-83 (Pubitemid 28243066)
7. Ebert M A 2000 Viability of the EUD and TCP concepts as reliable dose indicators Phys. Med. Biol. 45 441-57 (Pubitemid 30096774)
8. Fowler J F 2001 Biological factors influencing optimum fractionation in radiation therapy Acta Oncol. 40 712-7 (Pubitemid 33081979)
9. French J T, Goins B, Saenz M, Li S, Garcia-Rojas X, Phillips W T, Otto R A and Bao A 2010 Interventional therapy of head and neck cancer with lipid nanoparticle-carried rhenium 186 radionuclide J. Vasc. Interv. Radiol. 21 1271-9
10. Gabizon A A 2007 Applications of liposomal drug deliver systems to cancer therapy Nanotechnology for Cancer Therapy ed M M Amiji (Boca Raton, FL: CRC Press) pp 595-611
11. Giap H B, Macey D J, Bayouth J E and Boyer A L 1995 Validation of a dose-point kernel convolution technique for internal dosimetry Phys. Med. Biol. 40 365-81
12. Hall E J and Giaccia A J 2006 Radiobiology for the Radiobiologist 6th edn (Philadelphia, PA: Lippincott Williams & Wilkins) pp 303-4
13. Hrycushko B A, Li S, Shi C, Goins B, Liu Y, Phillips W T, Otto P M and Bao A 2011a Postlumpectomy focal brachytherapy for simultaneous treatment of surgical cavity and draining lymph nodes Int. J. Radiat. Oncol. Biol. Phys. 79 948-55
14. Hrycushko B A, Li S, Goins B, Otto R A and Bao A 2011b Direct intratumoral infusion of lipid nanoparticle-carried beta-emitting radionuclides for cancer therapy: effects of nonuniform intratumoral dose distribution Med. Phys. 38 1339-47
15. Kalogianni E, Flux G D and Malaroda A 2007 The use of BED and EUD concepts in heterogeneous radioactive distributions on a multicellular scale for targeted radionuclide therapy Cancer Biother. Radiopharm. 22 143-50 (Pubitemid 46697377)
16. Kawrakow I and Rogers D W 2000 The EGSnrc code system: Monte Carlo simulation of electron and photon transport Technical Report PIRS-701 (Ottawa: National Research Council of Canada)
17. Macey D J, Williams L E, Breitz H B, Liu A, Johnson T K and Zanzonico P B 2001 A primer for radioimmunotherapy and radionuclide therapy AAPM Report No 71 (Madison, WI: Medical Physics Publishing)
18. Maciejewski B, Withers H R, Taylor J M and Hliniak A 1989 Dose fractionation and regeneration for cancer of the oral cavity and oropharynx: tumor dose-response and repopulation Int. J. Radiat. Oncol. Biol. Phys. 16 831-43 (Pubitemid 19079722)
19. Mavroidis P, Tzikas A, Papanikolaou N and Lind B K 2010 Toolkit for determination of dose-response relations, validation of radiobiological parameters and treatment plan optimization based on radiobiological measures Technol. Cancer Res. Treat. 9 523-37
20. Milenic D E and Brechbiel M W 2004 Targeting of radio-isotopes for cancer therapy Cancer Biol. Ther. 3 361-70
21. Niemierko A 1997 Response to comment on 'reporting and analyzing dose distributions: a concept of equivalent uniform dose' Med. Phys. 24 1325-7
22. O'Donoghue J A 1999 Implications of nonuniform tumor doses for radioimmunotherapy J. Nucl. Med. 40 1337-41 (Pubitemid 29385643)
23. Order S E, Siegel J A, Principato R, Zeiger L E, Johnson E, Lang P, Lustig R and Wallner P E 1996 Selective tumor irradiation by infusional brachytherapy in nonresectable pancreatic cancer: a phase I study Int. J. Radiat. Oncol. Biol. Phys. 36 1117-26 (Pubitemid 27014498)
24. Patton J A, Townsend D W and Hutton B F 2009 Hybrid imaging technology: from dreams and vision to clinical devices Semin. Nucl. Med. 39 247-63
25. Prideaux A R, Song H, Hobbs R F, He B, Frey E C, Ladenson P W, Wahl R L and Sgouros G 2007 Three-dimensional radiobiologic dosimetry: application of radiobiological modeling to patient-specific 3-dimensional imaging-based internal dosimetry J. Nucl. Med. 48 1008-16 (Pubitemid 46909931)
26. Rogers D W, Kawrakow I, Seuntjens J P, Walters B R B and Mainegra-Hing E 2003 NRC user codes for EGSnrc Technical Report PIRS-702 (Ottawa: National Research Council of Canada)
27. 131I-anti-B1 antibody: assessment of tumor dose-response J. Nucl. Med. 44 260-8
28. 124I PET and 3-dimensional-internal dosimetry (3D-ID) software J. Nucl. Med. 45 1366-72 (Pubitemid 47618537)
29. Syme A, McQuarrie S and Fallone B G 2003 Beta dose-rate distributions in microscopic spherical tumors for intraperitoneal radioimmunotherapy Int. J. Radiat. Oncol. Biol. Phys. 56 1495-506 (Pubitemid 36842902)
30. Tome W A and Fowler J F 2002 On cold spots in tumor subvolumes Med. Phys. 29 1590-8 (Pubitemid 34774592)
31. Tomayko M M and Reynolds C P 1989 Determination of subcutaneous tumor size in athymic (nude) mice Cancer Chemother. Pharmacol. 24 148-54 (Pubitemid 19163397)
32. 186Re-liposome radionuclide therapy in a head and neck squamous cell carcinoma xenograft positive surgical margin model Clin. Cancer Res. 14 3975-83